Steve Dvorkin

Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity

Mathew R Schnorenberg, J. Hubbell, G. Randall, 2021, bioRxiv.

Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity

Mathew R Schnorenberg, J. Hubbell, G. Randall, 2021, ACS central science.

The Small t Antigen of JC Virus Antagonizes RIG-I-Mediated Innate Immunity by Inhibiting TRIM25’s RNA Binding Ability

Jessica J. Chiang, C. Chiang, M. Gack, 2021, mBio.

Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant

J. Hubbell, G. Randall, M. Swartz, 2021, bioRxiv.

Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors

Cooper A. Taylor, A. Joachimiak, G. Randall, 2020, Nature Communications.

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

M. Vignuzzi, A. Joachimiak, N. Heaton, 2021, Science.

Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro

N. Heaton, G. Randall, S. Tay, 2020, bioRxiv.

Robust estimation of bacterial cell count from optical density

Farren J. Isaacs, Marjolein E. Crooijmans, Dong Ju Kim, 2020, Communications Biology.